Barclays Downgrades CME Gr to Equal-Weight, Lowers Price Target to $222
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Budish downgraded CME Group (NASDAQ:CME) from Overweight to Equal-Weight and reduced the price target from $244 to $222.
January 08, 2024 | 1:27 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barclays analyst Benjamin Budish downgraded CME Group from Overweight to Equal-Weight and lowered the price target from $244 to $222.
Analyst downgrades typically lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The reduction in the price target further supports the expectation of a decrease in the stock's value in the eyes of investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100